from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2963/-

LFCtreatmentdescriptionclass of inhibitor

-0.671

Amikacinug/mL Amikacintranslation

-0.347

Cap5-10ug/mL Capreomycintranslation

-0.734

Rox10-50 ug/mL Roxithromycintranslation

-0.105

SM2-5 ug/mL Streptomycintranslation

-0.351

Tet5-10 ug/mL Tetracyclinetranslation

-0.631

Rif0.2-5ug/mL Rifampicintranscription

-0.372

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.616

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.455

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.128

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.039

Clofazimine10-13 ug/mL Clofaziminerespiration

0.239

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.700

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.206

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.792

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.411

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.263

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.211

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.243

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.921

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.119

KCN5-20 ug/mL Potassium cyaniderespiration

-0.120

NaN30.2-2 mM Sodium aziderespiration

-0.435

Nigericin50 uM Nigericinrespiration

-0.481

TRC10-150 ug/mL Triclosanrespiration

-0.089

TRZ10-25 ug/mL Thioridazinerespiration

0.989

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

2.131

menadione6-10 ug/mL Menadionerespiration

-0.239

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.234

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.932

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.074

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.042

NRP_1Non-replicating persistence stage 1dosRassociated

-0.199

Amp0.2mg/mL AmpicillincellWall

-0.252

Cephalexin20-100 ug/mL CephalexincellWall

0.022

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.231

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.176

EMB10-20 ug/mL EthambutolcellWall

0.471

Eta12-40 ug/mL EthionamidecellWall

0.255

INH0.2-0.4 ug/mL IsoniazidcellWall

0.506

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.377

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.016

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.017

BZA0.12 mg/mL BenzamidearomaticAmides

-0.082

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.522

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.319

H2O24 mM hydrogen peroxideDNAdamaging

-0.250

Levo10 ug/mL LevofloxacinDNAdamaging

-0.275

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.027

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.514

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.642

UVUV-irradiationDNAdamaging

4.960

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.575

Antimycin12.5-50 ug/mL Antimycin A?

-0.016

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.164

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.233

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.009

PA8240.2-2 ug/mL PA-824?

0.478

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.055

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.398

Verapamil50 uM Verapamil?

-0.396

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.049

methoxatin10-20 ug/mL Methoxatin?